abiliti system

abiliti system

A weight-loss system claimed to bring ease and accuracy to the weight-loss process by using food detection sensors implanted in the stomach (to track what the patient eats and drinks) and activity sensors to monitor the patient’s exercise behaviour.
References in periodicals archive ?
Jude Medical's Eon Mini Neurostimulator System, Boston Scientific's Precision Spinal Cord Stimulation System, Nevro's Senza System for Spinal Cord Stimulation, Cyberonics' VNS Therapy System, Codman & Shurtleff's Medstream system, Medtronic's Enterra Therapy System and IntraPace's abiliti system.
Data from a clinical study presented at the 5th Congress of the International Federation for the Surgery of Obesity and Metabolic Disorders European Chapter (IFSO-EC) in Barcelona, Spain, show that the abiliti system supports significant weight loss, is well tolerated and promotes behavioral changes.
The abiliti system combines gastric stimulation, which helps patients feel full sooner, and unique data collection and monitoring tools, to allow patients and doctors to constantly monitor progress (reduction in food intake and amount of exercise) and implement necessary lifestyle changes to maintain sustained weight loss.
For more information about the abiliti system and a free demonstration of the my.
The abiliti system is intended to enable patients to achieve and sustain significant weight loss without the complications, lifestyle restrictions and substantial anatomical changes associated with the established weight loss surgeries.
The device provides wireless access to personal eating and exercise data to patients with an abiliti system, a unique approach to the treatment of obesity that uses gastric stimulation to help patients feel full sooner.
The abiliti system employs food detection and activity sensors to continuously monitor and store a person's eating and exercise behavior on the implanted device.
Role will Oversee Continued Commercialization of abiliti System for Obesity
The company announced on March 30th that the first commercial patients in Europe had successfully received the abiliti system as a treatment for obesity.
announced today that the first commercial patients in Europe have successfully received the abiliti system as a treatment for obesity.
By enhancing the sense of fullness that a patient feels when they eat or drink, the abiliti system aids the patient in reducing the volume of food ingested.
announced today that it has received European CE Mark approval for the abiliti system as a treatment for obesity.